NDC 70518-4207-01 - Adenosine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4207
- Requested NDC
- 70518-4207-01
- Package NDCs from labels
- 70518-4207-1, 70518-4207-0, 70518-4207-3, 70518-4207-2, 70518-4207-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ADENOSINE INJECTION, USP FOR RAPID BOLUS INTRAVENOUS USE | REMEDYREPACK INC. | 2026-08-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4207-0 | Adenosine | 10 in 1 CARTON | INJECTION | 10 | 3 | |
| 70518-4207-1 | Adenosine | 2 mL in 1 VIAL | INJECTION | 2 | 3 | |
| 70518-4207-2 | Adenosine | 10 in 1 CARTON | INJECTION | 10 | 3 | |
| 70518-4207-3 | Adenosine | 4 mL in 1 VIAL | INJECTION | 4 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-4207 | ADENOSINE INJECTION [REMEDYREPACK INC.] | 2 | Current NDC, 4 package rows | 20241208_9508caf5-0e3a-4d32-909d-bff7ea40ec30.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.